Laurus Labs Stock

Laurus Labs EPS

The Earnings per Share (EPS) of Laurus Labs (LAURUSLABS.NS) as of Aug 7, 2026 is 6.64 INR. In the previous year, Earnings per Share (EPS) was 2.97 INR — a change of 123.21% (higher).

EPS

6.64INR

YoY

123.21%

Last updated:

Earnings per Share (EPS) of Laurus Labs is 2026 6.64 INR. Earnings per Share (EPS) of Laurus Labs was 2025 2.97 INR. It decreases by 123.21% higher compared to the previous year.
Access this data via the Eulerpool API

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

Earnings per Share (EPS) of Laurus Labs is 6.64 INR in 2026.

Earnings per Share (EPS) of Laurus Labs changed from 2.97 INR to 6.64 INR, representing a 123.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Laurus Labs

All Key Metrics — Laurus Labs